KEGG   COMPOUND: C00031
Entry
C00031                      Compound                               
Name
D-Glucose;
Grape sugar;
Dextrose;
Glucose;
D-Glucopyranose
Formula
C6H12O6
Exact mass
180.0634
Mol weight
180.16
Structure
Remark
Same as: D00009
Comment
alpha-D-Glucose [CPD:C00267]
beta-D-Glucose [CPD:C00221]
Reaction
Pathway
map00010  Glycolysis / Gluconeogenesis
map00030  Pentose phosphate pathway
map00052  Galactose metabolism
map00074  Mycolic acid biosynthesis
map00500  Starch and sucrose metabolism
map00520  Amino sugar and nucleotide sugar metabolism
map00521  Streptomycin biosynthesis
map00524  Neomycin, kanamycin and gentamicin biosynthesis
map00901  Indole alkaloid biosynthesis
map01100  Metabolic pathways
map01110  Biosynthesis of secondary metabolites
map02010  ABC transporters
map02020  Two-component system
map02060  Phosphotransferase system (PTS)
map04066  HIF-1 signaling pathway
map04068  FoxO signaling pathway
map04113  Meiosis - yeast
map04148  Efferocytosis
map04152  AMPK signaling pathway
map04742  Taste transduction
map04910  Insulin signaling pathway
map04911  Insulin secretion
map04917  Prolactin signaling pathway
map04922  Glucagon signaling pathway
map04930  Type II diabetes mellitus
map04931  Insulin resistance
map04932  Non-alcoholic fatty liver disease
map04933  AGE-RAGE signaling pathway in diabetic complications
map04973  Carbohydrate digestion and absorption
map04976  Bile secretion
map04978  Mineral absorption
map05111  Biofilm formation - Vibrio cholerae
map05230  Central carbon metabolism in cancer
map05415  Diabetic cardiomyopathy
Module
M00887  Mycolic acid biosynthesis, meromycolic acid + alpha-carboxyacyl-CoA + trehalose => TMM => TDM/mAGP/GMM
Network
nt06017  Glycogen metabolism
nt06535  Efferocytosis
Enzyme
1.1.1.118       1.1.1.119       1.1.1.121       1.1.1.359       
1.1.1.360       1.1.1.432       1.1.3.10        1.1.5.2         
1.1.5.9         1.1.99.28       1.1.99.35       2.3.1.72        
2.3.1.90        2.3.1.91        2.3.1.92        2.3.1.103       
2.3.1.143       2.3.1.152       2.3.1.-         2.4.1.8         
2.4.1.9         2.4.1.10        2.4.1.20        2.4.1.22        
2.4.1.25        2.4.1.31        2.4.1.64        2.4.1.99        
2.4.1.230       2.4.1.245       2.4.1.279       2.4.1.281       
2.7.1.1         2.7.1.2         2.7.1.41        2.7.1.42        
2.7.1.61        2.7.1.62        2.7.1.63        2.7.1.142       
2.7.1.147       2.7.1.199       3.1.1.33        3.1.3.9         
3.1.3.10        3.1.3.58        3.1.4.48        3.1.6.3         
3.2.1.3         3.2.1.10        3.2.1.20        3.2.1.21        
3.2.1.22        3.2.1.23        3.2.1.26        3.2.1.28        
3.2.1.39        3.2.1.42        3.2.1.45        3.2.1.48        
3.2.1.58        3.2.1.74        3.2.1.86        3.2.1.93        
3.2.1.104       3.2.1.105       3.2.1.107       3.2.1.108       
3.2.1.117       3.2.1.118       3.2.1.122       3.2.1.125       
3.2.1.126       3.2.1.147       3.2.1.175       3.2.1.182       
3.2.1.186       3.2.1.188       3.2.1.189       3.2.1.205       
3.2.1.206       3.2.1.207       3.2.1.208       3.2.1.216       
3.2.1.220       3.2.1.-         4.2.99.22       4.2.99.23
 » show all
Brite
Compounds with biological roles [BR:br08001]
 Carbohydrates
  Monosaccharides
   Aldoses
    C00031  D-Glucose
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
   B05C IRRIGATING SOLUTIONS
    B05CX Other irrigating solutions
     B05CX01 Glucose
      D00009  Glucose (JP18) <JP>
 V VARIOUS
  V04 DIAGNOSTIC AGENTS
   V04C OTHER DIAGNOSTIC AGENTS
    V04CA Tests for diabetes
     V04CA02 Glucose
      D00009  Glucose (JP18) <JP>
  V06 GENERAL NUTRIENTS
   V06D OTHER NUTRIENTS
    V06DC Carbohydrates
     V06DC01 Glucose
      D00009  Glucose (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  32  Nutrients, tonics
   323  Saccharide preparations
    3231  Glucoses
     D00009  Glucose (JP18); Purified glucose (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   Glucose
    D00009  Glucose (JP18)
Animal drugs in Japan [BR:br08331]
 96  Agents affecting metabolism
  964  Saccharide preparations and blood substitutes
   9641  Dextrose and preparations
    C00031  D-Glucose
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00009  Glucose
  D00009  Purified glucose
  D00009  Glucose injection
Other DBs
CAS: 50-99-7 2280-44-6
PubChem: 3333
ChEBI: 4167
KNApSAcK: C00042470
PDB-CCD: BGC[PDBj] GLC[PDBj]
NIKKAJI: J4.109B
LinkDB
KCF data

ATOM        12
            1   C1y C    24.2781  -16.5372
            2   C1y C    24.2781  -17.9377
            3   O2x O    25.4860  -15.8370
            4   C1b C    23.0643  -15.8370
            5   C1y C    25.4860  -18.6379
            6   O1a O    23.0643  -18.6379
            7   C1y C    26.7055  -16.5372
            8   O1a O    22.0023  -16.7474
            9   C1y C    26.7055  -17.9377
            10  O1a O    25.4860  -20.0383
            11  O1a O    27.9134  -15.8370
            12  O1a O    27.9134  -18.6379
BOND        12
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Up
            4     2   5 1
            5     2   6 1 #Down
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     5  10 1 #Up
            10    7  11 1 #Either
            11    9  12 1 #Down
            12    7   9 1

» Japanese version

DBGET integrated database retrieval system